Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation

Carmelo A. Milano, Vijaykumar Surendrakant Patel, Peter K. Smith, Mark Stafford Smith

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aprotinin has been shown to reduce transfusion requirements in re-operative cardiac surgery and in implantation of long-term left ventricular assist devices (LVAD). However, it is an antigenic polypeptide and re-exposure is associated with a small incidence of anaphylaxis. This report describes 2 cases of anaphylactic response to aprotinin when the agent was employed for both the LVAD implant and for the subsequent explant and cardiac transplant. Early re-exposure to just the test dose was associated with a significant incidence of anaphylaxis.

Original languageEnglish (US)
Pages (from-to)1127-1130
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume21
Issue number10
DOIs
StatePublished - Oct 1 2002
Externally publishedYes

Fingerprint

Device Removal
Aprotinin
Heart-Assist Devices
Anaphylaxis
Heart Transplantation
Incidence
Thoracic Surgery
Transplants
Peptides

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Cite this

Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation. / Milano, Carmelo A.; Patel, Vijaykumar Surendrakant; Smith, Peter K.; Smith, Mark Stafford.

In: Journal of Heart and Lung Transplantation, Vol. 21, No. 10, 01.10.2002, p. 1127-1130.

Research output: Contribution to journalArticle

@article{f220e183fe314b5994f738b33430d6dc,
title = "Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation",
abstract = "Aprotinin has been shown to reduce transfusion requirements in re-operative cardiac surgery and in implantation of long-term left ventricular assist devices (LVAD). However, it is an antigenic polypeptide and re-exposure is associated with a small incidence of anaphylaxis. This report describes 2 cases of anaphylactic response to aprotinin when the agent was employed for both the LVAD implant and for the subsequent explant and cardiac transplant. Early re-exposure to just the test dose was associated with a significant incidence of anaphylaxis.",
author = "Milano, {Carmelo A.} and Patel, {Vijaykumar Surendrakant} and Smith, {Peter K.} and Smith, {Mark Stafford}",
year = "2002",
month = "10",
day = "1",
doi = "10.1016/S1053-2498(02)00395-9",
language = "English (US)",
volume = "21",
pages = "1127--1130",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation

AU - Milano, Carmelo A.

AU - Patel, Vijaykumar Surendrakant

AU - Smith, Peter K.

AU - Smith, Mark Stafford

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Aprotinin has been shown to reduce transfusion requirements in re-operative cardiac surgery and in implantation of long-term left ventricular assist devices (LVAD). However, it is an antigenic polypeptide and re-exposure is associated with a small incidence of anaphylaxis. This report describes 2 cases of anaphylactic response to aprotinin when the agent was employed for both the LVAD implant and for the subsequent explant and cardiac transplant. Early re-exposure to just the test dose was associated with a significant incidence of anaphylaxis.

AB - Aprotinin has been shown to reduce transfusion requirements in re-operative cardiac surgery and in implantation of long-term left ventricular assist devices (LVAD). However, it is an antigenic polypeptide and re-exposure is associated with a small incidence of anaphylaxis. This report describes 2 cases of anaphylactic response to aprotinin when the agent was employed for both the LVAD implant and for the subsequent explant and cardiac transplant. Early re-exposure to just the test dose was associated with a significant incidence of anaphylaxis.

UR - http://www.scopus.com/inward/record.url?scp=0036796979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036796979&partnerID=8YFLogxK

U2 - 10.1016/S1053-2498(02)00395-9

DO - 10.1016/S1053-2498(02)00395-9

M3 - Article

C2 - 12398879

AN - SCOPUS:0036796979

VL - 21

SP - 1127

EP - 1130

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 10

ER -